Risk for work disability in incident patients with rheumatoid arthritis and spondyloarthritis varies between healthcare districts in Finland: an indicator of treatment effectiveness?

被引：0
|
作者：
Puolakka, K. [1 ]
Kautiainen, H. [2 ]
Rantalaiho, V. [3 ]
Virta, L. [4 ]
Sokka, T. [5 ]
Haanpaa, M. [6 ]
机构：
[1] South Karelia Cent Hosp, Dept Med, Lappeenranta, Finland
[2] Publ Hlth Res Ctr, Folkhalsan Hlth Res Ctr, Helsinki, Finland
[3] Univ Tampere, Fac Med & Life Sci, Tampere, Finland
[4] Social Insurance Inst, Res Unit, Turku, Finland
[5] Jyvaskyla Cent Hosp, Dept Med, Unit Rheumatol, Jyvaskyla, Finland
[6] Ilmarinen Mutual Pens Insurance Co, Helsinki, Finland
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2018年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP30
引用
收藏
页码：30 / 30
页数：1
相关论文
共 34 条
  • [31] Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure
    Park, Dong-Jin
    Choi, Sung-Eun
    Kang, Ji-Hyoun
    Shin, Kichul
    Sung, Yoon-Kyoung
    Lee, Shin-Seok
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [32] DIRECT COSTS, WORK PRODUCTIVITY LOSS, AND EFFECTIVENESS OF TREATMENT OF RHEUMATOID ARTHRITIS (RA) PATIENTS THROUGH A TREAT-TO-TARGET (T2T) APPROACH: A REAL-WORLD ADMINISTRATIVE DATABASE ANALYSIS
    Princic, N.
    Chu, B.
    Skup, M.
    Kalabic, J.
    Garg, V
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A540 - A540
  • [33] WORK RELATED OUTCOMES IN EARLY RHEUMATOID ARTHRITIS PATIENTS WITH ELEVATED RISK OF EMPLOYMENT LOSS: RESULTS FROM TWO RANDOMIZED CLINICAL TRIALS (OPTIMA AND PROWD) ON THE EFFECT OF ADALIMUMAB AND METHOTREXATE COMBINATION THERAPY VERSUS METHOTREXATE MONOTHERAPY OVER 6 MONTHS OF TREATMENT
    Emery, Paul
    Smolen, Josef
    Ganguli, Arijit
    Meerwein, Sebastian
    Bao, Yanjun
    Kupper, Hartmut
    Chen, Naijun
    Karunaratne, P. Mahinda
    Kavanaugh, Arthur
    [J]. RHEUMATOLOGY, 2014, 53 : 78 - 78
  • [34] The Association Between Treatment of Abatacept or Other Target Disease-Modifying Anti-rheumatic Drugs and Type 2 Diabetes Mellitus (T2DM)-Related Healthcare Resource Utilization and Costs in Commercially Insured Rheumatoid Arthritis Patients with T2DM
    Xia, Qian
    Han, Xue
    Bao, Ying
    Patel, Vardhaman
    Rajagopalan, Varshini
    Lobo, Francis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
1234